Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00203749
Status:
COMPLETED
Last Update Posted:
2013-12-12
First Post:
2005-09-13
Brief Title:
Community Mobilization Mobile Testing Same-Day Results and Post-Test Support for HIV in Sub-Saharan Africa and Thailand
Sponsor:
University of California Los Angeles
Organization:
University of California Los Angeles
Study Overview
Official Title:
NIMH Project Accept A Phase III Randomized Controlled Trial of Community Mobilization Mobile Testing Same-Day Results and Post-Test Support for HIV in Sub-Saharan Africa and Thailand
Status:
COMPLETED
Status Verified Date:
2013-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the effectiveness of a combination of clinic- and community-based voluntary counseling and testing programs in preventing HIV in African and Thai communities
Detailed Description:
NIMH Project Accept is an HIV prevention trial in which 48 communities 10 in Tanzania Kisarawe 8 in Zimbabwe Mutoko 8 in South AfricaVulindlela 8 in South AfricaSoweto and 14 in Thailand Chiang Mai are being randomized to receive either a community-based HIV voluntary counseling and testing CBVCT intervention plus standard clinic-based VCT SVCT or SVCT alone The CBVCT intervention has three major strategies 1 to make VCT more available in community settings 2 to engage the community through outreach and 3 to provide post-test support These strategies are designed to change community norms and reduce risk for HIV infection among all community members irrespective of whether they participated directly in the intervention
A community-level intervention based on modifying community norms can change the environmental context in which people make decisions about HIV risk and has the potential to alter the course of the HIV epidemic in developing countries This is the first international randomized controlled Phase III trial to determine the efficacy of a behavioralsocial science intervention with an HIV incidence endpoint
A community-level intervention based on modifying community norms can change the environmental context in which people make decisions about HIV risk and has the potential to alter the course of the HIV epidemic in developing countries This is the first international randomized controlled Phase III trial to determine the efficacy of a behavioralsocial science intervention with an HIV incidence endpoint
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U01MH066701 | NIH | None | None |
| U01MH066687 | NIH | None | None |
| U01MH066688 | NIH | None | None |
| U01MH066702 | NIH | None | None |
| DAHBR 9A-ASPG | US NIH GrantContract | None | httpsreporternihgovquickSearchU01MH066702 |